全文获取类型
收费全文 | 3356652篇 |
免费 | 246610篇 |
国内免费 | 8543篇 |
专业分类
耳鼻咽喉 | 46442篇 |
儿科学 | 112317篇 |
妇产科学 | 93092篇 |
基础医学 | 472438篇 |
口腔科学 | 92426篇 |
临床医学 | 304902篇 |
内科学 | 660427篇 |
皮肤病学 | 78480篇 |
神经病学 | 273002篇 |
特种医学 | 130185篇 |
外国民族医学 | 1282篇 |
外科学 | 505509篇 |
综合类 | 69784篇 |
现状与发展 | 6篇 |
一般理论 | 1221篇 |
预防医学 | 257626篇 |
眼科学 | 75870篇 |
药学 | 247494篇 |
9篇 | |
中国医学 | 6787篇 |
肿瘤学 | 182506篇 |
出版年
2019年 | 25878篇 |
2018年 | 36589篇 |
2017年 | 28013篇 |
2016年 | 32178篇 |
2015年 | 36270篇 |
2014年 | 50016篇 |
2013年 | 75549篇 |
2012年 | 101058篇 |
2011年 | 107113篇 |
2010年 | 64621篇 |
2009年 | 61789篇 |
2008年 | 100540篇 |
2007年 | 107043篇 |
2006年 | 108577篇 |
2005年 | 104516篇 |
2004年 | 101119篇 |
2003年 | 97679篇 |
2002年 | 94581篇 |
2001年 | 161231篇 |
2000年 | 165690篇 |
1999年 | 140200篇 |
1998年 | 40209篇 |
1997年 | 35784篇 |
1996年 | 35982篇 |
1995年 | 34699篇 |
1994年 | 32155篇 |
1993年 | 30134篇 |
1992年 | 110091篇 |
1991年 | 106352篇 |
1990年 | 103295篇 |
1989年 | 99737篇 |
1988年 | 91536篇 |
1987年 | 89830篇 |
1986年 | 84044篇 |
1985年 | 80308篇 |
1984年 | 60043篇 |
1983年 | 50844篇 |
1982年 | 29908篇 |
1981年 | 26993篇 |
1979年 | 53336篇 |
1978年 | 37491篇 |
1977年 | 31972篇 |
1976年 | 29652篇 |
1975年 | 31693篇 |
1974年 | 37323篇 |
1973年 | 35571篇 |
1972年 | 33270篇 |
1971年 | 30665篇 |
1970年 | 28571篇 |
1969年 | 26930篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
The long-term cost of effective management for benign prostatic hyperplasia (BPH) remains an important issue in pharmacoeconomics because about 25% of men aged 50 yr and older experience voiding problems due to BPH. With the ageing population and the increase in the percentage of patients with BPH for whom any type of treatment can be considered, a substantial increase in total costs to society can be expected. The up-front costs of interventional approaches to BPH are being replaced by a pattern of long-term medical and preventive therapy. The age-adjusted rate of transurethral resection of the prostate (TURP) reached a high point in 1987 and TURP rates, but not costs, have been in decline ever since. Mean 1-yr treatment costs (medical therapy and TURP) have been estimated in a pan-European study to be 858 Euros per patient, 75% of which were medication costs. Using a 2-yr time frame for treatment, Medicare costs for finasteride, terazosin, and TURP have been estimated as $3874, $2161, and $1820, respectively. The available models of the total long-term cost for all therapies for BPH remain compromised by a lack of inclusion of indirect costs, the lack of true long-term data and, critically, the lack of human cost information (patient preference). Only medical therapy provides a preventive as well as symptomatic potential and, if all of the issues were fully incorporated, it is likely that medical therapy would be increasingly recognised as economically preferable. 相似文献
993.
Migration of Kirschner (K) wires from the upper extremity joints has often been reported, but it is less common from the lower
extremities. In this report, we describe an 85-year-old man treated, during a hip replacement procedure, with a K-wire because
of a trochanteric fracture; after one year, the K-wire was found in the popliteal fossa. This report illustrates the first
case of K-wire migration in the popliteal area of the knee and suggests avoiding the use of free K-wires without any tension
banding. 相似文献
994.
Four clinical trials of porcine islet transplantation have been reported, and there are verbal reports that clinical trials on much larger scales are continuing in centers in China and Russia. The four reported trials are briefly reviewed and, in the light of the present status of experimental islet xenotransplantation, consideration is given to whether such trials are currently justified. The Ethics Committee of the International Xenotransplantation Association has (1) emphasized the need for encouraging studies in non-human primates before clinical trials should be undertaken, (2) mandatory monitoring for the transfer of porcine microorganisms, and (3) careful regulation and oversight by recognized bodies. Other aspects of the topic, such as the need for informed consent, are briefly discussed. We conclude that, at the present time, more data documenting convincing efficacy, focused on clinically applicable immunosuppressive regimens, are needed to justify the initiation of closely monitored clinical trials. A clinical trial may then be justified even though the potential risk to the patients, and possibly for society, will not be zero. 相似文献
995.
T. M. Egan S. Murray R. T. Bustami T. H. Shearon K. P. McCullough L. B. Edwards M. A. Coke E. R. Garrity S. C. Sweet D. A. Heiney F. L. Grover 《American journal of transplantation》2006,6(5P2):1212-1227
This article reviews the development of the new U.S. lung allocation system that took effect in spring 2005. In 1998, the Health Resources and Services Administration of the U.S. Department of Health and Human Services published the Organ Procurement and Transplantation Network (OPTN) Final Rule. Under the rule, which became effective in 2000, the OPTN had to demonstrate that existing allocation policies met certain conditions or change the policies to meet a range of criteria, including broader geographic sharing of organs, reducing the use of waiting time as an allocation criterion and creating equitable organ allocation systems using objective medical criteria and medical urgency to allocate donor organs for transplant. This mandate resulted in reviews of all organ allocation policies, and led to the creation of the Lung Allocation Subcommittee of the OPTN Thoracic Organ Transplantation Committee. This paper reviews the deliberations of the Subcommittee in identifying priorities for a new lung allocation system, the analyses undertaken by the OPTN and the Scientific Registry for Transplant Recipients and the evolution of a new lung allocation system that ranks candidates for lungs based on a Lung Allocation Score, incorporating waiting list and posttransplant survival probabilities. 相似文献
996.
997.
Coccidioidomycosis is an endemic fungal infection of the desert southwestern United States of particular concern for immunosuppressed renal transplant recipients. The clinical course of coccidioidomycosis can be severe in immunosuppressed patients, with high rates of dissemination and mortality, and antifungal prophylaxis is routinely administered to high-risk patients. We sought to determine the impact of coccidioidomycosis on patients who received their renal transplant at our hospital in Phoenix, Arizona. A retrospective records review of the first 205 patients who received a renal transplant between June 1999 and December 2003 identified 6 patients (3%) who had contracted coccidioidomycosis after transplantation. All six cases occurred more than 6 months after transplantation. Two of these six patients had disseminated coccidioidomycosis. Two patients, one with pulmonary infection and one with disseminated infection, died. None of the six patients with coccidioidomycosis after transplantation had identified risk factors before transplantation. No high-risk patient who received targeted antifungal prophylaxis had a reactivation of coccidioidomycosis after transplantation. Treatment for acute rejection and induction with antithymocyte globulin did not appear to increase the risk of subsequent coccidioidomycosis. 相似文献
998.
M. Lenartowicz M. Kowal D. Buda-Lewandowska J. Styrna 《Journal of inherited metabolic disease》2003,25(8):647-659
Summary: The mosaic (Atp7a
mo-ms
) is an X-linked, lethal mutation in mice. In mosaic mutant males, many clinical features characteristic of defective copper metabolism have been observed and they die at the age of 15 days, exhibiting strongsimilarities to the brindled and macular mutants. About 4% of the mutant males live to sexual maturity and some of them are fertile. In this paper, alterationsin the structure of the kidney from adult mutants are described. Owing to an inherited defect of efflux, copper is accumulated in the kidney of the mutants up to a toxic level and this leads to severe damage of the renal cortex. Pathological changes in the kidney mostly affected the structure of the renal corpuscle and renaltubules. 相似文献
999.
1000.
B Nkgudi K A Robertson J Volmink B M Mayosi 《Suid-Afrikaanse tydskrif vir geneeskunde》2006,96(3):206-208
OBJECTIVE: To determine whether under-reporting of rheumatic fever occurs at hospital, municipal, provincial and national levels of the South African health system. BACKGROUND: Information on the incidence of rheumatic fever (RF) and the prevalence of rheumatic heart disease (RHD) is required for the prevention of valvular heart disease in developing countries. In South Africa, RF was made a notifiable condition in 1989. It has recently been suggested that the reporting of RF cases may be incomplete, possibly because of underreporting by health care professionals and deficient administration of the disease notification system in South Africa. METHOD AND RESULTS: We assessed whether underreporting of RF cases occurs by comparing the numbers of RF cases reported per year at hospital, municipal, provincial and national levels from 1990 to 2004. There was a fall in the number of RF cases reported per year at national and provincial level over the 15 years of observation. A detailed analysis of the number of RF cases reported at hospital, municipal and provincial level for a 5-year period showed that more cases were diagnosed in one hospital (serving a smaller population) than were captured at municipal and provincial level (serving a larger population), suggesting underreporting by health care professionals. There were discrepancies in the number of cases reported at municipal, provincial and national level, suggesting poor administration of the notification system. CONCLUSION: There appears to be underreporting of RF cases by health care professionals, and poor administration of the RF notification system. Health care professionals need to be educated about the statutory requirement to notify all RF cases in South Africa. An effective national disease notification system is required. 相似文献